CytoPherx

Treatment of inflammation-based diseases and conditions using selective cytopheresis system
(Formerly Nephrion)

(2008)

Location:
Ann Arbor, MI

Management:
Jim Danehy, CEO; David Humes, CSO

UM Inventor(s):
H. David Humes

Funding parties:
Apjohn Ventures, Diamond Capital Management, Lurie Investments Inc., North Coast Technology Investors LP, Western Michigan University

Visit the Website